Hvis behandlingen med Diacomit fortsættes under amning, bør det ammende spædbarn observeres nøje for eventuelle bivirkninger.
In case Diacomit therapy is continued during breast-feeding, the breast-fed infant should be carefully observed for potential adverse effects.